Form 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of earliest event reported: September 13, 2004

 

 

Nuvelo, Inc.

(Exact Name of Registrant as Specified in Charter)

 

 

Delaware   000-22873   36-3855489

(State or Other Jurisdiction

of Incorporation)

   (Commission File Number)  

(I.R.S. Employer

Identification No.)

 

675 Almanor Avenue, Sunnyvale, California 94085

(Address of Principal Executive Offices) (Zip Code)

 

(408) 215-4000

(Registrant’s telephone number, including area code)

 

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

ITEM 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.

 

(b) Effective September 13, 2004, Philippe O. Chambon, MD, PhD, resigned from our Board of Directors.

 

(d) At its meeting on September 14, 2003, our Board of Directors elected Burton Sobel, MD as a director of Nuvelo, Inc. A press release announcing the appointment of Dr. Sobel entitled “Dr. Burton Sobel Joins Nuvelo Board of Directors” is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

 

ITEM 9.01. Financial Statements and Exhibits.

 

(c) Exhibits

 

99.1 Press release entitled “Dr. Burton Sobel Joins Nuvelo Board of Directors,” dated September 16, 2004.

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

   

Nuvelo, Inc.

(Registrant)

    By:  

/s/ Lee Bendekgey

        Lee Bendekgey
       

Senior Vice President, Chief Financial Officer and

General Counsel

Dated: September 16, 2004

        

Exhibit Index

 

Exhibit
Number
  

Description

99.1   Press release entitled “Dr. Burton Sobel Joins Nuvelo Board of Directors,” dated September 16, 2004.